581 related articles for article (PubMed ID: 23877479)
21. Splicing variants in sheep CLN3, the gene underlying juvenile neuronal ceroid lipofuscinosis.
Oswald MJ; Palmer DN; Damak S
Mol Genet Metab; 1999 Jun; 67(2):169-75. PubMed ID: 10356317
[TBL] [Abstract][Full Text] [Related]
22. Synapse alterations precede neuronal damage and storage pathology in a human cerebral organoid model of CLN3-juvenile neuronal ceroid lipofuscinosis.
Gomez-Giro G; Arias-Fuenzalida J; Jarazo J; Zeuschner D; Ali M; Possemis N; Bolognin S; Halder R; Jäger C; Kuper WFE; van Hasselt PM; Zaehres H; Del Sol A; van der Putten H; Schöler HR; Schwamborn JC
Acta Neuropathol Commun; 2019 Dec; 7(1):222. PubMed ID: 31888773
[TBL] [Abstract][Full Text] [Related]
23. Molecular mechanisms of the juvenile form of Batten disease: important role of MAPK signaling pathways (ERK1/ERK2, JNK and p38) in pathogenesis of the malady.
Shematorova EK; Shpakovski DG; Chernysheva AD; Shpakovski GV
Biol Direct; 2018 Sep; 13(1):19. PubMed ID: 30621751
[TBL] [Abstract][Full Text] [Related]
24. Strategy for mutation detection in CLN3: characterisation of two Finnish mutations.
Munroe PB; O'Rawe AM; Mitchison HM; Järvelä IE; Santavuori P; Lerner TJ; Taschner PE; Gardiner RM; Mole SE
Neuropediatrics; 1997 Feb; 28(1):15-7. PubMed ID: 9151312
[TBL] [Abstract][Full Text] [Related]
25. Altered arginine metabolism in the central nervous system (CNS) of the Cln3-/- mouse model of juvenile Batten disease.
Chan CH; Ramirez-Montealegre D; Pearce DA
Neuropathol Appl Neurobiol; 2009 Apr; 35(2):189-207. PubMed ID: 19284480
[TBL] [Abstract][Full Text] [Related]
26. Coding sequence and exon/intron organization of the canine CLN3 (Batten disease) gene and its exclusion as the locus for ceroid-lipofuscinosis in English setter dogs.
Shibuya H; Liu PC; Katz ML; Siakotos AN; Nonneman DJ; Johnson GS
J Neurosci Res; 1998 May; 52(3):268-75. PubMed ID: 9590435
[TBL] [Abstract][Full Text] [Related]
27. Deterioration of visual quality and acuity as the first sign of ceroid lipofuscinosis type 3 (CLN3), a rare neurometabolic disease.
Purzycka-Olewiecka JK; Hetmańczyk-Sawicka K; Kmieć T; Szczęśniak D; Trubicka J; Krawczyński M; Pronicki M; Ługowska A
Metab Brain Dis; 2023 Feb; 38(2):709-715. PubMed ID: 36576693
[TBL] [Abstract][Full Text] [Related]
28. Microglia in juvenile neuronal ceroid lipofuscinosis are primed toward a pro-inflammatory phenotype.
Xiong J; Kielian T
J Neurochem; 2013 Oct; 127(2):245-58. PubMed ID: 23919525
[TBL] [Abstract][Full Text] [Related]
29. A novel mutation af Cln3 associated with delayed-classic juvenile ceroid lipofuscinois and autophagic vacuolar myopathy.
Licchetta L; Bisulli F; Fietz M; Valentino ML; Morbin M; Mostacci B; Oliver KL; Berkovic SF; Tinuper P
Eur J Med Genet; 2015 Oct; 58(10):540-4. PubMed ID: 26360874
[TBL] [Abstract][Full Text] [Related]
30. Hippocampal volumes in juvenile neuronal ceroid lipofuscinosis: a longitudinal magnetic resonance imaging study.
Tokola AM; Salli EK; Åberg LE; Autti TH
Pediatr Neurol; 2014 Feb; 50(2):158-63. PubMed ID: 24411222
[TBL] [Abstract][Full Text] [Related]
31. Deletion of the Caenorhabditis elegans homologues of the CLN3 gene, involved in human juvenile neuronal ceroid lipofuscinosis, causes a mild progeric phenotype.
de Voer G; van der Bent P; Rodrigues AJ; van Ommen GJ; Peters DJ; Taschner PE
J Inherit Metab Dis; 2005; 28(6):1065-80. PubMed ID: 16435200
[TBL] [Abstract][Full Text] [Related]
32. Defective lysosomal arginine transport in juvenile Batten disease.
Ramirez-Montealegre D; Pearce DA
Hum Mol Genet; 2005 Dec; 14(23):3759-73. PubMed ID: 16251196
[TBL] [Abstract][Full Text] [Related]
33. Glial cells are functionally impaired in juvenile neuronal ceroid lipofuscinosis and detrimental to neurons.
Parviainen L; Dihanich S; Anderson GW; Wong AM; Brooks HR; Abeti R; Rezaie P; Lalli G; Pope S; Heales SJ; Mitchison HM; Williams BP; Cooper JD
Acta Neuropathol Commun; 2017 Oct; 5(1):74. PubMed ID: 29041969
[TBL] [Abstract][Full Text] [Related]
34. First case of genetically confirmed CLN3 disease in Chinese with cDNA sequencing revealing pathogenicity of a novel splice site variant.
Lau NKC; Ching CK; Lee HHC; Chak WKM; Kwan Shing N; Hanchard NA; Mak CM
Clin Chim Acta; 2018 Nov; 486():151-155. PubMed ID: 30053402
[TBL] [Abstract][Full Text] [Related]
35. A mouse gene knockout model for juvenile ceroid-lipofuscinosis (Batten disease).
Katz ML; Shibuya H; Liu PC; Kaur S; Gao CL; Johnson GS
J Neurosci Res; 1999 Aug; 57(4):551-6. PubMed ID: 10440905
[TBL] [Abstract][Full Text] [Related]
36. Altered gene expression in the eye of a mouse model for batten disease.
Chattopadhyay S; Kingsley E; Serour A; Curran TM; Brooks AI; Pearce DA
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2893-905. PubMed ID: 15326100
[TBL] [Abstract][Full Text] [Related]
37. [From gene to disease; from CLN1, CLN2 and CLN3 to neuronal ceroid lipofuscinosis].
Taschner PE; Losekoot M; Breuning MH; Hofman I; van Diggelen OP
Ned Tijdschr Geneeskd; 2005 Feb; 149(6):300-3. PubMed ID: 15730038
[TBL] [Abstract][Full Text] [Related]
38. The Batten disease gene CLN3 confers resistance to endoplasmic reticulum stress induced by tunicamycin.
Wu D; Liu J; Wu B; Tu B; Zhu W; Luo J
Biochem Biophys Res Commun; 2014 Apr; 447(1):115-20. PubMed ID: 24699413
[TBL] [Abstract][Full Text] [Related]
39. Modulation of Kv4.2/KChIP3 interaction by the ceroid lipofuscinosis neuronal 3 protein CLN3.
Seifert C; Storch S; Bähring R
J Biol Chem; 2020 Aug; 295(34):12099-12110. PubMed ID: 32641494
[TBL] [Abstract][Full Text] [Related]
40. A novel deletion variant in CLN3 with highly variable expressivity is responsible for juvenile neuronal ceroid lipofuscinoses.
Gilani N; Razmara E; Ozaslan M; Abdulzahra IK; Arzhang S; Tavasoli AR; Garshasbi M
Acta Neurol Belg; 2021 Jun; 121(3):737-748. PubMed ID: 33783722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]